Radioiodine Refractory Differentiated Thyroid Carcinoma

EP. 1: Phase 3 SELECT Trial Overview

ByTargeted Oncology
July 13th 2020

EP. 2: SELECT Trial: Toxicity, Duration of Response, and Dose Reduction

ByTargeted Oncology
July 13th 2020

EP. 3: What is Radioiodine-Refractory DTC?

ByTargeted Oncology
July 13th 2020

EP. 4: Radioiodine-Refractory DTC: NCCN Guidelines

ByTargeted Oncology
July 13th 2020

EP. 5: Multikinase Inhibitor Overall Survival Advantage

ByTargeted Oncology
July 13th 2020